ALK-Abello A/S Enters Collaboration To Accelerate Growth In China

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALK (ALK-B.CO / OMX: ALK B / AKABY / AKBLF) and China-based specialty pharmaceutical company Eddingpharm, today announced that they have agreed a collaboration that will expand ALK’s presence in China. Under the agreement, Eddingpharm will handle the sales and distribution of ALK’s marketed products in China, while ALK will support Eddingpharm with medical and scientific expertise. ALK will maintain a local organisation in China.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC